Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Greco

Showing results (61-70 of 190) with videos related to

Pageof 19
Sort By:
The FEBS Journal|September 3, 2019
Corrigendum: Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretomeGiulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Bone Marrow Transplantation|October 9, 2021
Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipientsElisabetta Xue, Francesca Lorentino, Daniela Clerici, et al.
Arthritis Research & Therapy|October 24, 2024
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agentsNicoletta Del Papa, Silvia Cavalli, Andrea Rindone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow TransplantationGiacomo Boffa, Angela Genchi, Alice Mariottini, et al.
Cells|November 11, 2022
Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative ApproachesElisabetta Xue, Antonina Minniti, Tobias Alexander, et al.
Neoplasia (New York, N.Y.)|March 10, 2015
A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapyRosa Angela Cardone, Maria Raffaella Greco, Katrine Zeeberg, et al.
Frontiers in Nutrition|May 24, 2024
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses GroupChiara Gandossi, Helen Jessop, Anne Hahn, et al.
The Lancet. Haematology|April 30, 2025
Urgent need: evidence-based use of donor lymphocyte infusions - Authors' replySimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Bone Marrow Transplantation|February 2, 2019
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Helen Jessop, Dominique Farge, Riccardo Saccardi, et al.
Pageof 19

Showing results (61-70 of 190) with videos related to

Sort By:
Pageof 19
The FEBS Journal|September 3, 2019
Corrigendum: Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretomeGiulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Bone Marrow Transplantation|October 9, 2021
Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipientsElisabetta Xue, Francesca Lorentino, Daniela Clerici, et al.
Arthritis Research & Therapy|October 24, 2024
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agentsNicoletta Del Papa, Silvia Cavalli, Andrea Rindone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow TransplantationGiacomo Boffa, Angela Genchi, Alice Mariottini, et al.
Cells|November 11, 2022
Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative ApproachesElisabetta Xue, Antonina Minniti, Tobias Alexander, et al.
Neoplasia (New York, N.Y.)|March 10, 2015
A novel NHE1-centered signaling cassette drives epidermal growth factor receptor-dependent pancreatic tumor metastasis and is a target for combination therapyRosa Angela Cardone, Maria Raffaella Greco, Katrine Zeeberg, et al.
Frontiers in Nutrition|May 24, 2024
Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses GroupChiara Gandossi, Helen Jessop, Anne Hahn, et al.
The Lancet. Haematology|April 30, 2025
Urgent need: evidence-based use of donor lymphocyte infusions - Authors' replySimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Bone Marrow Transplantation|February 2, 2019
General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Helen Jessop, Dominique Farge, Riccardo Saccardi, et al.
Pageof 19